Pro Share Advisors LLC Bridge Bio Pharma, Inc. Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 48,539 shares of BBIO stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,539
Previous 37,675
28.84%
Holding current value
$1.75 Million
Previous $959,000
38.79%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
177MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$908 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$903 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$542 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$448 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$222 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.33B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...